Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 150Unknown 77Recruiting 61Terminated 56Active not recruiting 55Not yet recruiting 16Withdrawn 15Suspended 2Enrolling by invitation 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Head & Neck 1

Conditions

Recurrent Head and Neck Carcinoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

Specimen Handling 11Cyclophosphamide 9Magnetic Resonance Spectroscopy 8pembrolizumab 6Cisplatin 6Bevacizumab 6Radiosurgery 5Oxaliplatin 5Nivolumab 5Irinotecan 5Fluorouracil 5Everolimus 5Capecitabine 5venetoclax 4Vincristine 4S 1 (combination) 4Prednisone 4Leucovorin 4Etoposide 4Drug Therapy 4Doxorubicin 4Azacitidine 4fludarabine phosphate 3fludarabine 3Tacrolimus 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Rituximab 3Radiotherapy 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × OTHER × Radiotherapy, Intensity-Modulated × Clear all
NCT02333162 2026-03-30

Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

University of Chicago

Phase 1 Suspended
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03164460 2026-03-20

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 2 Suspended
68 enrolled
Head & Neck

Recurrent Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡